Table 2.
Baseline-characteristics (physical examination, laboratory parameters, blood pressure) (t0) of the 143 patients included in the trial and completed it. * median.
| Parameter | MW ± SD | Min. | Max. |
|---|---|---|---|
| Number (n) | 143 | - | - |
| Age (years) | 13.9 ± 2.4 | 9.3 | 18.4 |
| Females (%) | 62 | - | - |
| Height (m) | 1.62 ± 0.12 | 1.30 | 1.97 |
| Weight (kg) | 84.1 ± 22.6 | 40.8 | 155.2 |
| BMI (kg/m2) | 31.2 ± 5.4 | 20.3 | 51.4 |
| BMI-SDS | 2.51 ± 0.57 | 0.6 | 4.0 |
| Obesity (%) | 56 | - | - |
| Duration of inhouse treatment (days) | 40.4 ± 4.1 | 28 | 49 |
| Fasting blood-glucose (mmol/L) | 4.17 ± 0.5 | 2.0 | 5.1 |
| oGTT: Blood-glucose 2 h after glucose-loading (mmol/L) | 5.2 ± 0.8 | 3.0 | 6.9 |
| Pathological oGTT (%) | 0 | - | - |
| Total cholesterol (mmol/L) | 4.5 ± 0.9 | 2.6 | 7.4 |
| Total cholesterol ≥ 5.2 mmol/L (%) | 25 | - | - |
| LDL-cholesterol (mmol/L) | 2.8 ± 0.8 | 1.2 | 5.8 |
| LDL-cholesterol ≥ 2.6 mmol/L (%) | 73 | - | - |
| HDL-cholesterol (mmol/L) | 1.6 ± 0.3 | 0.9 | 2.6 |
| HDL-cholesterol < 1.0 mmol/L (%) | 5 | - | - |
| Triglycerides (mmol/L) | 1.1 ± 0.5 | 0.4 | 2.9 |
| Triglycerides ≥ 1.70 mmol/L (%) | 18 | - | - |
| TSH (μIU/mL) | 2.9 ± 1.3 | 0.2 | 7.8 |
| Hypothyreosis (TSH > 4.00 μIU/mL) (%) | 21 | - | - |
| Uric acid (μmol/L) | 359.8 ± 83.3 | 191.0 | 631.0 |
| Hyperuricaemia (≥ 440 μmol/L) (%) | 24 | - | - |
| CRP (mg/dL) | 0.5 * | 0.5 | 4.0 |
| CRP > 0.5 mg/dL (%) | 34 | - | - |
| Systolic blood pressure (mmHg) | 121.7±9.2 | 99 | 150 |
| Systolic blood pressure > 140 mmHg (%) | 4 | - | - |
| Diastolic blood pressure (mmHg) | 68.3 ± 6.5 | 55 | 84 |
| Diastolic blood pressure > 80 mmHg (%) | 2 | - | - |
| 24-h-blood pressure systolic (mmHg) | 119.0 ± 9.4 | 95 | 150 |
| 24-h-blood pressure diastolic (mmHg) | 65.9 ± 6.5 | 51 | 81 |
| Systolic day-/night-difference (mmHg) | 16.1 ± 9.1 | 2 | 35 |
| Diastolic day-/night-difference (mmHg) | 11.5 ± 7.6 | 0 | 24 |